{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.89C>T",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "C",
            "alt": "T",
            "position": "89"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "30"
          },
          "Description in input context": "A30P variant"
        },
        {
          "HGVS": "NM_000340.3:c.137A>G",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "A",
            "alt": "G",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "G",
            "position": "46"
          },
          "Description in input context": "E46K variant"
        },
        {
          "HGVS": "NM_000340.3:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005316"
  },
  "Experiment Method": [
    {
      "Assay Method": "Solution NMR spectroscopy",
      "Material used": {
        "Material Source": "Protein",
        "Material Name": "R-synuclein variants (A30P, E46K, A53T)",
        "Description": "Analysis of phospholipid binding properties of R-synuclein variants using solution NMR spectroscopy."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.89C>T",
          "Conclusion": "Decreased lipid affinity",
          "Molecular Effect": "Intermediate effect",
          "Result Description": "A30P variant showed decreased lipid affinity compared to wild-type."
        },
        {
          "Variant": "NM_000340.3:c.137A>G",
          "Conclusion": "Increased lipid affinity",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "E46K variant showed increased lipid affinity compared to wild-type."
        },
        {
          "Variant": "NM_000340.3:c.157G>A",
          "Conclusion": "Comparable lipid affinity",
          "Molecular Effect": "Intermediate effect",
          "Result Description": "A53T variant showed lipid affinity comparable to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described in the abstract."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the abstract."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Standard NMR binding parameters for wild-type R-synuclein",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Deviation from wild-type binding parameters (e.g., >20% change in lipid affinity)",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}